NCT07473583 Pneumoperitoneum Duration and Bicarbonate Changes in Laparoscopic Hernia Surgery
| NCT ID | NCT07473583 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Haseki Training and Research Hospital |
| Condition | Hernia, Inguinal |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-03-10 |
| Primary Completion | 2026-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2026-03-10 with a primary completion date of 2026-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to learn how the length of pneumoperitoneum during laparoscopic inguinal hernia surgery may affect changes in blood bicarbonate levels. Pneumoperitoneum is the use of carbon dioxide gas to create space inside the abdomen during laparoscopic surgery. The main question this study aims to answer is whether a longer pneumoperitoneum time is associated with changes in blood bicarbonate levels after surgery. Participants are adults undergoing laparoscopic inguinal hernia repair as part of their routine medical care. Researchers will measure blood gas values, including bicarbonate levels, before surgery and again two hours after surgery. The change in bicarbonate levels will be compared with the duration of pneumoperitoneum during the operation. The results of this study may help improve the understanding of metabolic changes that occur during laparoscopic surgery.
Eligibility Criteria
Inclusion Criteria: * Age ≥18 years * Patients undergoing laparoscopic inguinal hernia repair using the TAPP technique * Ability to provide informed consent Exclusion Criteria: * Pregnancy * Severe cardiovascular disease * Renal insufficiency * Patients requiring additional intra-abdominal surgical procedures * Strangulated inguinal hernia requiring bowel resection
Contact & Investigator
Muzaffer Akinci, MD
PRINCIPAL INVESTIGATOR
Haseki Training and Research Hospital
Frequently Asked Questions
Who can join the NCT07473583 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hernia, Inguinal. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07473583 currently recruiting?
Yes, NCT07473583 is actively recruiting participants. Contact the research team at osmansibic@gmail.com for enrollment information.
Where is the NCT07473583 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07473583 clinical trial?
NCT07473583 is sponsored by Haseki Training and Research Hospital. The principal investigator is Muzaffer Akinci, MD at Haseki Training and Research Hospital. The trial plans to enroll 100 participants.